LivaNova PLC: LivaNova Announces First Patient Implanted in

Study to evaluate effectiveness of hypoglossal nerve stimulation LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced the first patient implanted

Related Keywords

Florida , United States , California , San Diego , Tampa Bay , Morton Plant Hospital , London , City Of , United Kingdom , Damien Mcdonald , Deanna Wilke , Baycare Morton , Corporate Communications , Baycare Health System , Professor Of Medicine At University California , Nasdaq , Obstructive Sleep Apnea , Targeted Hypoglossal , Mitchell Miller , Atul Malhotra , Principal Investigator , Livanova Chief Executive , Plant Hospital , Annual Report , Quarterly Reports , Current Reports , Lancet Respir Med , World Journal , Neck Surgery , Enova Investor Relations , Media Contacts , Investor Relations , Livanova , Nnounces , First , Patient , Implanted , Osprey , Linical , Study , Patients , Coping , Obstructive , Sleep , Apnea ,